ANATOMIC STAGE I BREAST CANCER AJCC V8
Clinical trials for ANATOMIC STAGE I BREAST CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new ANATOMIC STAGE I BREAST CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for ANATOMIC STAGE I BREAST CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising combo for Hard-to-Treat breast cancer hits roadblock
Disease control TerminatedThis study tested a combination of two drugs (nab-paclitaxel and alpelisib) given before surgery to people with a specific type of triple-negative breast cancer that didn't respond to standard chemotherapy. The goal was to see if the combo could shrink or eliminate tumors. Only 6…
Matched conditions: ANATOMIC STAGE I BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 05:13 UTC
-
New hope for tough breast cancer: drug aims to boost immune attack
Disease control TerminatedThis study tested the drug abemaciclib in 26 women with triple negative breast cancer that did not respond to standard chemotherapy. The goal was to see if the drug could increase immune cell activity in the tumor before surgery. The trial was stopped early, but results may help …
Matched conditions: ANATOMIC STAGE I BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 05:08 UTC
-
Can an app help breast cancer patients stick with lifesaving pills?
Symptom relief TerminatedThis study tested a web-based app designed to help people with early-stage hormone-positive breast cancer take their daily hormone therapy as prescribed. Many patients stop taking these pills due to side effects or lack of support, which can increase the risk of cancer returning.…
Matched conditions: ANATOMIC STAGE I BREAST CANCER AJCC V8
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated May 26, 2026 05:15 UTC
-
Hot flash drug studied in breast cancer patients – trial cut short
Symptom relief TerminatedThis study tested fezolinetant, a drug for hot flashes and night sweats, in women with breast cancer taking hormone therapy. The trial aimed to see if the drug could reduce the number and severity of these symptoms. Only 9 people took part before the study was stopped early.
Matched conditions: ANATOMIC STAGE I BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Symptom relief
Last updated May 26, 2026 05:15 UTC
-
New program aims to boost Well-Being in young black breast cancer survivors
Symptom relief TerminatedThis study tested a program to improve quality of life for young African American women who finished treatment for early or late-stage breast cancer. About 27 women took part in either the program or a comparison group. The goal was to see if the program helped with physical, emo…
Matched conditions: ANATOMIC STAGE I BREAST CANCER AJCC V8
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated May 26, 2026 05:06 UTC
-
Can a gut pill stop chemo stomach woes? trial tests rifaximin for breast cancer patients
Symptom relief TerminatedThis study tested the antibiotic rifaximin in 20 people with early-stage HER2-positive breast cancer who had stomach problems from pertuzumab-based chemotherapy. The goal was to see if rifaximin could reduce side effects like diarrhea and belly pain, helping patients stay on thei…
Matched conditions: ANATOMIC STAGE I BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 18, 2026 12:07 UTC